About: Physicochemistry, pharmacokinetics, and pharmacodynamics of S‐nitrosocaptopril crystals, a new nitric oxide donor††Abbreviations: CapNO, S‐nitrosocaptopril; Cap, Captopril; RSNOs, S‐nitrosothiols; ACE, angiotensin converting enzyme; MAP, me

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Physicochemistry, pharmacokinetics, and pharmacodynamics of S‐nitrosocaptopril crystals, a new nitric oxide donor††Abbreviations: CapNO, S‐nitrosocaptopril; Cap, Captopril; RSNOs, S‐nitrosothiols; ACE, angiotensin converting enzyme; MAP, me Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована в жовтні 1999 (uk) article scientifique publié en 1999 (fr) im Oktober 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1999 (ast) scientific article published on 01 October 1999 (en)
publication date	wds:Q58641867-3585EC82-F1F1-4F4F-8C9F-6E8E7D3E3E23
publication date	1999-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58641867-FDE214B3-E623-4CBC-A51D-0C3CA5B019DE
language of work or name	English
cites work	wds:Q58641867-01BB647B-A7EC-4BCE-82EF-DE375374D0CC wds:Q58641867-0295CB56-D208-475F-9806-D1BB7F9F85F4 wds:Q58641867-39CE37DD-9601-4E1C-94D6-4346FBA183DC wds:Q58641867-3DD8FE2B-AD4F-46EC-A436-BBEC76424E80 wds:Q58641867-4074D927-2E00-4FC4-84B9-2846F57FA9CE wds:Q58641867-4449ED89-59F8-45A0-B22A-E9071AA050EC wds:Q58641867-5AEE4165-2123-434E-8151-B1B0847E19EC wds:Q58641867-727BBAAD-BB87-491F-A4BF-130D46093560 wds:Q58641867-76601DF9-7174-44BE-ACCF-D002D5E819CA wds:Q58641867-84A89B48-249E-47E8-AD6D-CB6AD101595D wds:Q58641867-85080276-D13B-43B8-B9B8-7CFA536066D8 wds:Q58641867-A3336ED5-BA7A-4769-AD44-73E62E6019F4 wds:Q58641867-A42422D3-8644-4395-8284-F5CDD5B26958 wds:Q58641867-D799C409-86EA-4000-9978-233B152863DD wds:Q58641867-F30DD786-8C21-411B-909F-2386491F7585 wds:Q58641867-F39F4095-5BDE-4158-B41E-829FB6D14FFE wds:Q58641867-F4807B79-C20F-44AA-AD02-52D7D6E48518 wds:Q58641867-F7257464-DF83-4357-91DE-4D8228B3E3E5 wds:Q58641867-F92AD3D8-DD1E-458A-AA2B-A3F31557FEE4 wds:Q58641867-FCF374F3-1110-427C-8076-D88B616242C4
cites work	S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide The estimation of nitrate and nitrite in saliva and urine The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Mechanism of nitric oxide release from S-nitrosothiols Tissue sulfhydryl groups Blood Flow Regulation by S-Nitrosohemoglobin in the Physiological Oxygen Gradient S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary Molecular mechanisms and therapeutic strategies related to nitric oxide. Kinetics and equilibria of S-nitrosothiol-thiol exchange between glutathione, cysteine, penicillamines and serum albumin Captopril: pharmacology, metabolism and disposition Captopril disulfide conjugates may act as prodrugs: Disposition of the disulfide dimer of captopril in the rat Dual actions of S-nitrosylated derivative of vasoactive intestinal peptide as a vasoactive intestinal peptide-like mediator and a nitric oxide carrier The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats. Dual role of S-nitrosocaptopril as an inhibitor of angiotensin-converting enzyme and a nitroso group carrier Differential inhibition of platelet aggregation and calcium mobilization by nitroglycerin and stabilized nitric oxide S-nitrosothiols and role of metal ions in decomposition to nitric oxide An interactive program for pharmacokinetic modeling. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo. Nitric oxide and hypertension
author name string	wds:Q58641867-044429E6-3A4F-4078-B4EA-824593381526 wds:Q58641867-792C98DC-A265-452D-9099-C4F6F2DE3AD6
author name string	W Guo X Young
rdfs:label	Physicochemistry, pharmacokinetics, and pharmacodynamics of S‐nitrosocaptopril crystals, a new nitric oxide donor††Abbreviations: CapNO, S‐nitrosocaptopril; Cap, Captopril; RSNOs, S‐nitrosothiols; ACE, angiotensin converting enzyme; MAP, me (en) Physicochemistry, pharmacokinetics, and pharmacodynamics of S‐nitrosocaptopril crystals, a new nitric oxide donor††Abbreviations: CapNO, S‐nitrosocaptopril; Cap, Captopril; RSNOs, S‐nitrosothiols; ACE, angiotensin converting enzyme; MAP, me (nl)
skos:prefLabel	Physicochemistry, pharmacokinetics, and pharmacodynamics of S‐nitrosocaptopril crystals, a new nitric oxide donor††Abbreviations: CapNO, S‐nitrosocaptopril; Cap, Captopril; RSNOs, S‐nitrosothiols; ACE, angiotensin converting enzyme; MAP, me (en) Physicochemistry, pharmacokinetics, and pharmacodynamics of S‐nitrosocaptopril crystals, a new nitric oxide donor††Abbreviations: CapNO, S‐nitrosocaptopril; Cap, Captopril; RSNOs, S‐nitrosothiols; ACE, angiotensin converting enzyme; MAP, me (nl)
name	Physicochemistry, pharmacokinetics, and pharmacodynamics of S‐nitrosocaptopril crystals, a new nitric oxide donor††Abbreviations: CapNO, S‐nitrosocaptopril; Cap, Captopril; RSNOs, S‐nitrosothiols; ACE, angiotensin converting enzyme; MAP, me (en) Physicochemistry, pharmacokinetics, and pharmacodynamics of S‐nitrosocaptopril crystals, a new nitric oxide donor††Abbreviations: CapNO, S‐nitrosocaptopril; Cap, Captopril; RSNOs, S‐nitrosothiols; ACE, angiotensin converting enzyme; MAP, me (nl)
author	wds:Q58641867-846E10D4-1F57-41D7-BD0C-DF37C47295CE
author	Lee Jia
title	wds:Q58641867-A480C1FF-EFF9-4E7A-8930-9E4BFBB86AC0
title	Physicochemistry, pharmacokinetics, and pharmacodynamics of S-nitrosocaptopril crystals, a new nitric oxide donor (en)
page(s)	wds:Q58641867-40522D1B-5AEF-4AE6-B377-14021AA73B2F
page(s)	981-986
instance of	wds:Q58641867-AF8734C3-5DBA-4815-8D4D-D6AA51913296
instance of	scholarly article
main subject	wds:Q58641867-A90BFDB6-B715-4EA8-B7FD-08EABF67BEFA
main subject	pharmacokinetics
PubMed ID	wds:Q58641867-405C1B00-31F0-4A7B-9AD4-F0A137C83F4C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10514343
PubMed ID	10514343
published in	wds:Q58641867-AFA31DB3-9F72-4B29-9255-151C94BF6E8F
published in	Journal of Pharmaceutical Sciences
issue	wds:Q58641867-3E1B5F2F-4293-4B31-B936-2B94FF015A04
volume	wds:Q58641867-CBF72070-4536-41E1-AEAB-95BB77AA59E2
issue	10
volume	88
DOI	wds:Q58641867-0CC91026-8A59-4806-9EA2-C5D90B7F930E
DOI	http://dx.doi.org/10.1021/JS990108G
DOI	10.1021/JS990108G
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58641867
is cites work of	Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug Nitric oxide inhibits hetero-adhesion of cancer cells to endothelial cells: restraining circulating tumor cells from initiating metastatic cascade. Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry Pharmacokinetic comparison of intravenous carbendazim and remote loaded carbendazim liposomes in nude mice Inorganic sulfur-nitrogen compounds: from gunpowder chemistry to the forefront of biological signaling In vitro and in vivo assessment of cellular permeability and pharmacodynamics of S-nitrosylated captopril, a nitric oxide donor S-nitrosocaptopril: in vitro characterization of pulmonary vascular effects in rats An update on hybrid drugs in cardiovascular drug research Acute and subacute toxicity and efficacy of S-nitrosylated captopril, an ACE inhibitor possessing nitric oxide activities The conduct of drug metabolism studies considered good practice (I): analytical systems and in vivo studies Antiangiogenic effects of S-nitrosocaptopril crystals as a nitric oxide donor Reactions of S-nitrosothiols with L-ascorbic acid in aqueous solution Biostability and pharmacokinetics of LJP 920, an octameric Gal (alpha1-3) Gal conjugate for the inhibition of xenotransplantation rejection. S-nitrosocaptopril: acute in-vivo pulmonary vasodepressor effects in pulmonary hypertensive rats.
is cites work of	wds:Q38090661-4062F843-498E-48A8-A3BA-EB7937475811

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software